| || |
Special Internet Prices.
Fast & Guaranteed Worldwide Delivery!
Secure & FAST Online Ordering.
Our Drugstore Is The Most Trusted Online Drug Supplier.
Daughton CG. "Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal, waste reduction, and future directions." Environmental Health Perspectives 2003, 111(5):775-785; doi:10.1289/ehp.5948.
Daughton CG. "Groundwater recharge and chemical contaminants: Challenges in communicating the connections and collisions of two disparate worlds." Ground Water Monitoring & Remediation 2004, 24(2):127-138; doi:10.1111/j.1745-6592.2004.tb00721.x.
Daughton CG. "Non-regulated water contaminants: emerging research." Environmental Impact Assessment Review 2004, 24(7-8):711-732; doi:10.1016/j.eiar.2004.06.003.
Daughton CG. "PPCPs in the environment: Future research - beginning with the end always in mind." in Pharmaceuticals in the environment - Coreg 3.125 Mg Sources, fate, effects and risks, 2nd Edition; K�mmerer K, Ed., Springer; Berlin, Germany, 2004, Chapter 33, pp 463-496; http://www.epa.gov/nerlesd1/bios/daughton/researchneeds-chapter.pdf.
Daughton CG. "Emerging chemicals as pollutants in the environment: a 21st century perspective." Renewable Resources Journal 2005, 23(4):6-23.
Daughton CG. "Origins and Fate of PPCPs in the Environment." Poster Presentation, USEPA, NERL, Las Vegas, NV, 2006; http://www.epa.gov/nerlesd1/bios/daughton/drawing.pdf.
Daughton CG. "Emerging Pollutants - Questions, Challenges, and the Future." Network of Reference Laboratories for Monitoring of Emerging Environmental Pollutants, EU, Guest Editorial, Ed., Stresa, Italy, 2006, 15 pp; available: http://www.norman-network.net/index_php.php?module=public/others/newsletter and http://www.norman-network.net/newsletters/newsletter_norman_1.pdf.
Daughton CG. "The Environmental Life Cycle of Pharmaceuticals [illustration published in: Daughton, C.G. "Pharmaceuticals as Environmental Pollutants: the Ramifications for Human Exposure," In: International Encyclopedia of Public Health, Kris Heggenhougen and Stella Quah (Eds.), Vol. 5, San Diego: Academic Press; 2008, pp. 66-102]." Published Illustration, USEPA, Las Vegas, NV, December 2006; http://www.epa.gov/esd/bios/daughton/illicit-drug-lifecycle.pdf.
Daughton CG. "Pharmaceuticals in the environment: sources and their management." in Analysis, Fate and Removal of Pharmaceuticals in the Water Cycle, Petrovi? M and Barcel� D, Eds., Elsevier Science; Amsterdam, The Netherlands, 2007, Volume Volume 50, Chapter 1, pp 1-58; doi:10.1016/S0166-526X(07)50001-2; http://www.elsevier.com/wps/find/bookdescription.cws_home/712147/description#description.
Daughton CG. "Pharmaceuticals as environmental pollutants: the ramifications for human exposure." in International Encyclopedia of Public Health, Heggenhougen K and Quah S, Eds., Academic Press; Oxford, England, 2008, Volume 5, pp 66-102; doi:10.1016/B978-012373960-5.00403-2; http://www.sciencedirect.com/science/article/pii/B9780123739605004032; pre-galley version: http://www.epa.gov/nerlesd1/bios/daughton/EoPH2008.pdf.
Daughton CG. "Drug Usage and Disposal: Overview of Environmental Stewardship and Pollution Prevention (with an emphasis on activities in the Federal Government)." US EPA, Office of Research and Development, Environmental Sciences Division, Las Vegas, Nevada, prepared for Research Triangle Environmental Health Collaborative - Health Summit, "Pharmaceuticals in Water: What We Know, Don't Know, and Should Do," 10-11 November 2008 North Carolina Biotechnology Center, Research Triangle Park, North Carolina, 15 October, 2008, 24 pp; available: http://environmentalhealthcollaborative.org/summit/presentations-and-materials/; http://environmentalhealthcollaborative.org/images/ChristianDaughtonAbstract.pdf.
Daughton CG. "Drug Usage and Disposal: Overview of Environmental Stewardship and Pollution Prevention." invited overview for Research Triangle Environmental Health Collaborative - Health Summit, "Pharmaceuticals in Water: What We Know, Don't Know, and Should Do," 10-11 November 2008 North Carolina Biotechnology Center, Research Triangle Park, North Carolina, 2008; http://environmentalhealthcollaborative.org/summit/presentations-and-materials/; http://environmentalhealthcollaborative.org/images/ChristianDaughtonPresentation.pdf.
Daughton CG. "Chemicals from the practice of healthcare: Challenges and unknowns posed by residues in the environment." Environmental Toxicology and Chemistry 2009, 28(12):2490-2494; doi:10.1897/09-138.1,10.1897/09-138.S1, 10.1897/09-138.S2.
Daughton CG. "Peering into the shadows of chemical space. Emerging contaminants and environmental science: is either being served by the other?" presented at 2nd International Conference on Occurrence, Cost Of Coreg Fate, Effects, and Analysis of Emerging Contaminants in the Environment (EmCon09), opening address, Fort Collins, Colorado, 4-7 August, 2009; http://www.epa.gov/esd/bios/daughton/Daughton-abstract-EmCon09.pdf.
Daughton CG. "Role of PharmEcovigilance: Minimizing Human & Ecological Impacts [illustration published in: Daughton CG and Ruhoy IS "The Afterlife of Drugs and the Role of PharmEcovigilance," Drug Safety, 2008, 31(12):1069-1082]." Illustration, USEPA, Las Vegas, NV, 7 December 2009 (rev 17 June 2010) 2009; http://www.ingentaconnect.com/content/adis/dsf/2008/00000031/00000012/art00004.
Daughton CG. "Illicit Drugs and the Environment [illustration published in: Daughton CG "Illicit Drugs: Contaminants in the Environment and Utility in Forensic Epidemiology," Reviews of Environmental Contamination and Toxicology, in press, March 2011)]." Illustration, USEPA, Las Vegas, NV, 7 December 2009 (rev 17 June 2010) 2009.
Daughton CG. "Emerging contaminants and the ramifications for environmental science." Environmental Sciences Division, NERL, ORD, USEPA, Las Vegas, NV, 2010.
Daughton CG. "Emerging contaminants and the ramifications for environmental science." presented at NorCal SETAC annual meeting "PPCPs and other Emerging Contaminants", University of California, Berkeley, Clark Kerr Campus, US Environmental Protection Agency, 13 May, 2010; http://www.epa.gov/esd/bios/daughton/NorCal-SETAC-2010.pdf.
Daughton CG. "Drugs and the Environment: Stewardship & Sustainability." National Exposure Research Laboratory, Environmental Sciences Division, US EPA, Las Vegas, NV, 12 September, 2010, 196 pp; available: http://www.epa.gov/nerlesd1/bios/daughton/APM200-2010.pdf.
Daughton CG. "Pharmaceuticals and Sustainability." invited presentation for Ecopharmacovigilance for a Healthy Future, under the Distinguished Patronage of the Honorable Minister of Environment, Science and Technology, Ghana; workshop during ISoP (International Society of Pharmacovigilance) 10th Annual Meeting, University of Ghana Medical School, Accra (Ghana), 4 November 2010; http://www.isop2010.org/.
Daughton CG. "Pharmaceutical Ingredients in Drinking Water: Overview of Occurrence and Significance of Human Exposure." in Contaminants of Emerging Concern in the Environment: Ecological and Human Health Considerations, Halden RU, Ed., American Chemical Society; Washington, DC, 2010, ACS Symposium Series 1048, Chapter 2, pp 9-68; doi:10.1021/bk-2010-1048.ch002; http://dx.doi.org/10.1021/bk-2010-1048.ch002.
Daughton CG. "Illicit Drugs: Contaminants in the Environment and Utility in Forensic Epidemiology." Reviews of Environmental Contamination and Toxicology 2011, 210:59-110; doi:10.1007/978-1-4419-7615-4_3.
Daughton CG. "Illicit Drugs and the Environment." in Illicit drugs in the environment: Occurence, analysis, and fate using mass spectrometry, Castiglioni S, Zuccato E and Fanelli R, Eds., John Wiley & Sons, Inc.; Hoboken, NJ, 2011, Chapter 1, pp 3-27; doi:10.1002/9781118000816.ch1; http://onlinelibrary.wiley.com/doi/10.1002/9781118000816.ch1/summary; http://www.amazon.com/Spectrometric-Analysis-Illicit-Drugs-Environment/dp/0470529547#reader_0470529547.
Daughton CG. "Pharmaceuticals and sustainability." presented at Drugs in the Environment - Ecopharmacovigilance for Better Health, London, UK, Royal Society of Medicine (RSM), 31 October, 2011; http://www.rsm.ac.uk/academ/epc01.php; http://www.epa.gov/esd/bios/daughton/RSM-2011.pdf.
Daughton CG. "Real-time estimation of small-area populations with human biomarkers in sewage." Science of the Total Environment 2012, 414:6-21; doi:10.1016/j.scitotenv.2011.11.015.
Daughton CG. "Office of Research and Development Superfund and Technology Liaison (STL) Region 9 Newsletter: Web Pages." ORD Superfund and Technology Liaison, Region 9, US Environmental Protection Agency, San Francisco, CA, Edition 58, 2012. 15 pp.
Daughton CG. "Comment on "Life Cycle Comparison of Environmental Emissions from Three Disposal Options for Unused Pharmaceutical"." Environmental Science & Technology 2012, In press.
Daughton CG and Brooks BW. "Active pharmaceutical ingredients and aquatic organisms." in Environmental Contaminants in Biota: Interpreting Tissue Concentrations, 2nd Edition; Coreg 12.5 Mg Beyer WN and J. M, Eds., CRC Press, Taylor and Francis; Boca Raton, FL, 2011, Chapter 8, pp 287-347; http://www.taylorandfrancis.com/books/details/9781420084054/; http://www.epa.gov/esd/bios/daughton/APIs-aquaticbiota.pdf.
Daughton CG and Jones-Lepp T, Eds., "Pharmaceuticals and Personal Care Products in the Environment: Scientific and Regulatory Issues." American Chemical Society, Washington, DC, 2001, ACS Symposium Series 791, 396 pp; doi:10.1021/bk-2001-0791; http://www.epa.gov/nerlesd1/bios/daughton/book.htm or http://pubs.acs.org/isbn/9780841237391?prevSearch=&searchHistoryKey=.
Daughton CG and Jones-Lepp TL. "Preface." in Pharmaceuticals and Personal Care Products in the Environment: Scientific and Regulatory Issues, Daughton CG and Jones-Lepp TL, Eds., American Chemical Society; Washington, DC, 2001, ACS Symposium Series 791, Chapter Preface, pp xi-xvi; doi:10.1021/bk-2001-0791.pr001; http://pubs.acs.org/action/showMultipleAbstracts; http://pubs.acs.org/doi/pdfplus/10.1021/bk-2001-0791.pr001.
Daughton CG and Ruhoy IS. "Pharmaceuticals in the Environment - - Why Should Anyone Care?" guest editorial." KNAPPE: Knowledge and Need Assessment on Pharmaceutical Products in Environmental Waters, October, 2007, 6 pp; available: http://www.knappe-eu.org/fichiers/41-Newsletter 2 OCT 2007-1 (D6.2.2).pdf.
Daughton CG and Ruhoy IS. "The afterlife of drugs and the role of pharmEcovigilance." Drug Safety 2008, 31(12):1069-1082.
Daughton CG and Ruhoy IS. "PharmEcovigilance: Aligning Pharmacovigilance with Environmental Protection." in An Introduction to Environmental Pharmacology, Rahman SZ, Shahid M and Gupta V, Eds., Ibn Sina Academy; Aligarh, India, 2008, Chapter 1 (Introductory Overview), pp 21-34; http://www.epa.gov/nerlesd1/bios/daughton/IntroEnvironPharmacol-Chapter1-2008.pdf.
Daughton CG and Ruhoy IS. "Accumulation and disposal of leftover medications: A key aspect of pharmEcovigilance." in An Introduction to Environmental Pharmacology, Rahman SZ, Shahid M and Gupta V, Eds., Ibn Sina Academy; Aligarh, India, 2008, Chapter 5, pp 101-107; http://www.epa.gov/nerlesd1/bios/daughton/IntroEnvironPharmacol-Chapter5-2008.pdf.
Daughton CG and Ruhoy IS. "Environmental footprint of pharmaceuticals: The significance of factors beyond direct excretion to sewers." Environmental Toxicology and Chemistry 2009, 28(12):2495-2521; doi:10.1897/08-382.1.
Daughton CG and Ruhoy IS. "Pharmaceuticals and Sustainability: Concerns and Opportunities Regarding Human Health and the Environment." in A Healthy Future- Pharmaceuticals in a Sustainable Society, collaborative publication of Apoteket AB, MistraPharma, and Stockholm County Council; Stockholm, Sweden, 2009, Chapter 1, pp 14-39; http://www.mistrapharma.se/download/18.1fe8f33123572b59ab800011033/A+Healthy+Future.pdf.
Daughton CG and Ruhoy IS. "Pharmaceuticals in the Environment - Why Should We Care?" in Pharmaceuticals in the Environment: Current Knowledge and Need Assessment to Reduce Presence and Impact, Roig B, Ed., IWA Publishing; London, UK, 2010, Chapter Foreword, pp xiii-xvii; http://www.iwapublishing.com/template.cfm?name=isbn9781843393146.
Daughton CG and Ruhoy IS. "Reducing the Ecological Footprint of Pharmaceutical Usage: Linkages between Healthcare Practices and the Environment." in Green and Sustainable Pharmacy, K�mmerer K and Hempel M, Eds., Springer-Verlag; Berlin Heidelberg, Germany, 2010, Chapter 6, pp 77-102; doi:10.1007/978-3-642-05199-9_6; http://www.springerlink.com/content/v1883001v254v12q/fulltext.pdf; http://www.springer.com/environment/environmental+management/book/978-3-642-05198-2.
Daughton CG and Ruhoy IS. "Green Pharmacy and PharmEcovigilance: Prescribing and the Planet." Expert Review of Clinical Pharmacology 2011, 4(2):211-232; doi:10.1586/ecp.11.6.
Daughton CG and Ternes TA. "Pharmaceuticals and personal care products in the environment: Agents of subtle change?" Environmental Health Perspectives 1999, 107(suppl 6):907-938; doi:10.2307/3434573.
Daughton CG and Ternes TA. "Erratum: Pharmaceuticals and personal care products in the environment: agents of subtle change? (Environ. Health Perspect. 1999, 107(suppl 6), 907-938)." Environmental Health Perspectives 2000, 108(3):598.
Da?valos LM, Bejarano AC, Hall MA, Correa HL, Corthals A, and Espejo OJ. "Forests and Drugs: Coca-Driven Deforestation in Tropical Biodiversity Hotspots." Environmental Science & Technology 2011, 45(4):1219-1227; doi:10.1021/es102373d.
Davarani SSH, Pourahadi A, Nojavan S, Banitaba MH, and Nasiri-Aghdam M. "Electro membrane extraction of sodium diclofenac as an acidic compound from wastewater, urine, bovine milk, and plasma samples and quantification by high-performance liquid chromatography." Analytica Chimica Acta 2012, 722:55-62; doi:10.1016/j.aca.2012.02.012.
Dave G and Herger G. "Determination of detoxification to Daphnia magna of four pharmaceuticals and seven surfactants by activated sludge." Chemosphere 2012, 88(4):459-466; doi:10.1016/j.chemosphere.2012.02.070.
David A and Pancharatna K. "Developmental anomalies induced by a non-selective COX inhibitor (Ibuprofen) in zebrafish, (Danio rerio)." Environmental Toxicology and Pharmacology 2009, 27(3):390-395; doi:10.1016/j.etap.2009.01.002.
David B, Carwardine E, and Longmore RBea. "Some results of a campaign for the collection of unused medications in Perth [*citation not verified]." Australian Journal of Pharmacy 1979, 60:350-353.
David RM. "Exposure to phthalate esters." Environmental Health Perspectives 2000, 108(10):A440.
Davidson AW. "The Disposal of Pharmaceutical Waste." Perspectives in Public Health 1989, 109(3):110-111; doi:10.1177/146642408910900313.
Davies AJ and Maillard JY. "Bacterial adaptation to biocides: the possible role of 'alarmones'." Journal of Hospital Infection 2001, 49(4):300-302; doi:10.1053/jhin.2001.1104.
Davies IM, Gillibrand PA, McHenery JG, and Rae GH. "Environmental risk of ivermectin to sediment dwelling organisms." Aquaculture 1998, 163(1):29-46; doi:10.1016/S0044-8486(98)00211-7.
Davies IM, McHenery JG, and Rae GH. "Environmental risk from dissolved ivermectin to marine organisms." Aquaculture 1997, 158(3-4):263-275; doi:10.1016/S0044-8486(97)00209-3.
Davies IM, Rodger GK, Redshaw J, and Stagg RM. "Targeted environmental monitoring for the effects of medicines used to treat sea-lice infestation on farmed fish." ICES Journal of Marine Science 2001, 58(2):477-485; doi:10.1006/jmsc.2000.1040.
Davies ML, Lofthouse TJ, and Stamm JM. "Aquatic photodegradation of 14C-sarafloxicin hydrochloride." Abstracts of Papers - American Chemical Society 1993, S205:91.
Davis AS, Wingfield CL, Forrester CW, Guthrie MK, and McNew JL. "Streamlining outpatient drug therapy at a Veterans Affairs medical center." American Journal of Health-System Pharmacy 1997, 54(23):2719-2720.
Davis EF, Klosterhaus SL, and Stapleton HM. "Measurement of flame retardants and triclosan in municipal sewage sludge and biosolids." Environment International 2012, 40(0):1-7; doi:10.1016/j.envint.2011.11.008.
Davis J. 2012, "Texas Tech Forensic Science Student Uses New Technique Coreg Cr Coupon to Flush Out Evidence of Cocaine Use in Lubbock-s Sewage Purchase Coreg Water: When it comes to cocaine, users of the drug in Lubbock abuse up to a third more on the weekends." Texas Tech University, Lubbock, TX, 12 June, 2 pp; http://today.ttu.edu/2012/06/texas-tech-forensic-science-student-uses-new-technique-to-flush-out-evidence-of-cocaine-use-in-lubbockâs-sewage-water/.
Davis JG, Truman CC, Kim SC, Ascough JC, and Carlson K. "Antibiotic transport via runoff and soil loss." Journal of Environmental Quality 2006, 35(6):2250-2260.
Davis KB, Morrison J, and Galvez JI. "Reproductive characteristics of adult channel catfish treated with trenbolone acetate during the phenocritical period of sex differentiation." Aquaculture 2000, 189(3-4):351-360; doi:10.1016/S0044-8486(00)00378-1.
Davis LK, Visitacion N, Riley LG, Hiramatsu N, Sullivan CV, Hirano T, et al. "Effects of o,p'-DDE, heptachlor, and 17?-estradiol on vitellogenin gene expression and the growth hormone/insulin-like growth factor-I axis in the tilapia, Oreochromis mossambicus." Comparative Biochemistry and Physiology, Part C 2009, 149(4):507-514; doi:10.1016/j.cbpc.2008.11.007.
Davis M. 2010, "SMED: The Band-Aid That Looked Like a Miracle Cure." The Street Sweeper on Facebook, 14 October, http://www.thestreetsweeper.org/article.html?c=3&i=1228.
Davis R, "A Guide to Purified Sewage." Environmental News, 25 April, 2010, http://www.voiceofsandiego.org/environment/article_4be66c84-50b0-11df-8318-001cc4c002e0.html.
Davis-Bruno KL and Atrakchi A. "A Regulatory Perspective on Issues and Approaches in Characterizing Human Metabolites." Chemical Research in Toxicology 2006, 19(12):1561-1563; doi:10.1021/tx060203m.
Related links: Buy Indinavir, etodolac 300mg cap teva usa, clomipramine msds, online retin a, valtrex 500mg or 1g, luvox discount cards, non-prescription minoxidil, celexa 20mg tablets, do you need a prescription for lamisil cream, zithromax on line
| || |